Other
Stockholm3
Stockholm3 is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Not yet recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
not_yet_recruiting267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruiting
Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)
NCT07478536
not_yet_recruiting
Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered Validation
NCT06573736
completed
Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population
NCT05294627
Clinical Trials (3)
Showing 3 of 3 trials
NCT07478536
Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)
NCT06573736
Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered Validation
NCT05294627
Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3